Conclusions This review indicates that it is still unclear whether patient education is beneficial and whether it has a significant and clinical ly relevant impact on osteoporosis management results .
Summary This review summarizes evidence regarding the effects of patient education in osteoporosis prevention and treatment .
Method ological improvem ent of future RCTs ( e.g. with regard to r and omization and duration of follow-up ) might yield more conclusive evidence on the effects of patient education in osteoporosis Introduction This review aims to evaluate the effects of patient education on osteoporosis prevention and treatment results .
Predictors of bone mineral density testing in patients at high risk of osteoporosis: secondary analyses from the OSTEOPHARM randomized trial.
In a r and omized trial , we demonstrated that a community pharmacist osteoporosis screening intervention doubled the rates of bone mineral density ( BMD ) testing in high-risk patients . The purpose of this secondary analysis was to evaluate the potentially modifiable factors associated with BMD testing .  From 2005 to 2007 , 15 pharmacies r and omized 262 patients to intervention ( education , pamphlets , point-of-care quantitative heel ultrasound [ QUS ] ) or usual care . The main outcome was BMD testing within 4mo . Multivariate regression was used to determine independent correlates of BMD testing .  The median age of the cohort was 62yr , 65 % were women , and 49 % ( n=129 ) were r and omized to intervention . Compared with patients who were not tested , those with BMD were more likely to be women ( p=0.007 ) and have excellent or very good health ( p<0.001 ) . Postr and omization correlates of BMD test were intervention ( p=0.017 ) , greater osteoporosis knowledge ( p=0.004 ) , and osteoporosis-specific physician visits ( p<0.001 ) . In adjusted analyses , only female sex ( adjusted odds ratio [ aOR ] : 3.0 ; 95 % confidence interval [ CI ] : 1.3 - 7.4 ) and osteoporosis-specific visits ( aOR : 3.2 ; 95 % CI : 1.4 - 7.8 ) were independently associated with BMD testing . In analyses restricted to intervention patients , abnormal QUS ( aOR : 3.7 , 95 % CI : 1.4 - 9.1 ) was the only independent predictor of BMD test . Future interventions should incorporate the finding that osteoporosis-specific visits and abnormal QUS results were strongly associated with getting a BMD testing and should give greater attention to men
Conclusions This review indicates that it is still unclear whether patient education is beneficial and whether it has a significant and clinical ly relevant impact on osteoporosis management results .
Summary This review summarizes evidence regarding the effects of patient education in osteoporosis prevention and treatment .
Method ological improvem ent of future RCTs ( e.g. with regard to r and omization and duration of follow-up ) might yield more conclusive evidence on the effects of patient education in osteoporosis Introduction This review aims to evaluate the effects of patient education on osteoporosis prevention and treatment results .